Article
Type 5 phosphodiesterase expression is a critical determinant of the endothelial cell angiogenic phenotype.
American journal of physiology. Lung cellular and molecular physiology - 1 Feb 2009
Zhu Bing, Zhang Li, Alexeyev Mikhail, Alvarez Diego F, Strada Samuel J, Stevens Troy
Abstract excerpt
Type 5 phosphodiesterase (PDE5) inhibitors increase endothelial cell cGMP and promote angiogenesis. However, not all endothelial cell phenotypes express PDE5. Indeed, whereas conduit endothelial cells express PDE5, microvascular endothelial cells do not express this enzyme, and they are rapidly angiogenic. These findings bring into question whether PDE5 activity is a critical determinant of the endothelial cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
